Lymphoma Hub,
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large ... Event-free survival at…
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Overview of attention for article published in Journal of Clinical Oncology, February 2014
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (84th percentile)
Mentioned by
- policy
- 3 policy sources
- 24 X users
- patent
- 1 patent
- googleplus
- 1 Google+ user
- 1 Redditor
- guideline
- 4 clinical guideline sources
Readers on
- mendeley
- 313 Mendeley